Mainstay Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Mainstay Capital Management's LLY Position: Q2 2026 in Review
Mainstay Capital Management reduced its Eli Lilly (LLY) stake by 3.8% in Q2 2026, selling an estimated $62.3K and leaving 1,557 shares worth $1.87M. The position accounts for 0.14% of the portfolio, ranked #52.
Mainstay Capital Management first reported a position in LLY in Q4 2017 and has held it in 16 quarters since. The position peaked at $2.3M in Q2 2025. 4,630 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Mainstay Capital Management held 1,557 shares of Eli Lilly worth $1.87M as of Q2 2026.
- Mainstay Capital Management sold 61 Eli Lilly shares in Q2 2026, an estimated $62.3K.
- Eli Lilly made up 0.14% of Mainstay Capital Management's portfolio in Q2 2026, its #52 holding.
- Mainstay Capital Management first reported a position in Eli Lilly in Q4 2017 and has held it in 16 quarters since.
- Mainstay Capital Management's Eli Lilly position peaked at $2.3M in Q2 2025.
- 4,630 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Mainstay Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.